In order to implement these responsibilities the authority must command powers of enforcement backed by legal provision for penal sanction against offenders.
In establishing administrative mechanisms for decision-making, the regulatory authority should not lose necessary flexibility. In particular, it should make provision for:
(a) implementing decisions regarded as urgent in the interest of public safety; and
(b) formal consultation (usually through representative bodies) with pharmaceutical companies and other interested parties, including pharmacists, doctors, nurses, and patients.